This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Mgenplus Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Eun Jin Lee - Innovator in Transgenic Cloning
Introduction
Eun Jin Lee is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biotechnology, particularly in the area of transgenic cloning. Her innovative work has the potential to impact medical research and therapeutic applications.
Latest Patents
Eun Jin Lee holds a patent for a "Transgenic cloned piglet expressing human proinsulin and method of producing the same." This invention involves a transgenic cloned piglet that expresses human proinsulin, along with a method for its production. The patent details a recombinant vector for human proinsulin expression, a genetically modified cell line, and the process of creating the transgenic cloned piglet.
Career Highlights
Eun Jin Lee is associated with Mgenplus Co., Ltd., where she continues to advance her research in genetic engineering and biotechnology. Her work is recognized for its potential to contribute to advancements in diabetes treatment and other medical fields.
Collaborations
Eun Jin Lee collaborates with notable colleagues, including Jung-Taek Kang and Bumrae Cho. Their combined expertise enhances the research and development efforts at Mgenplus Co., Ltd.
Conclusion
Eun Jin Lee's innovative work in transgenic cloning exemplifies the intersection of biotechnology and medical research. Her contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile